Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension (vol 27, pg S15, 2017)

被引：0

作者：

Gupta, Fiona ^{[1
]}

Karabin, Beverly ^{[2
]}

Mehdirad, Ali ^{[3
,4
]}

机构：

[1] Hackensack Univ, Med Ctr, Movement Disorders Ctr, Hackensack, NJ USA

[2] Univ Toledo, Syncope & Auton Disorders Ctr, 2801 W Bancroft St, Toledo, OH 43606 USA

[3] St Louis Univ, Dept Internal Med, Div Cardiol, Cardiac Electrophysiol Sect, St Louis, MO USA

[4] St Louis Univ, Dept Internal Med, St Louis, MO USA

来源：

CLINICAL AUTONOMIC RESEARCH | 2017年 / 27卷 / 06期

关键词：

D O I：

10.1007/s10286-017-0458-y

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：431 / 431

页数：1

共 30 条

[1] Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Gupta, Fiona
Karabin, Beverly
Mehdirad, Ali
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S15 - S16
[2] Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Fiona Gupta
Beverly Karabin
Ali Mehdirad
Clinical Autonomic Research, 2017, 27 : 15 - 16
[3] Erratum to: Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Fiona Gupta
Beverly Karabin
Ali Mehdirad
Clinical Autonomic Research, 2017, 27 : 431 - 431
[4] Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Goodman, Brent P.
Claassen, Daniel
Mehdirad, Ali
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S17 - S19
[5] Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Brent P. Goodman
Daniel Claassen
Ali Mehdirad
Clinical Autonomic Research, 2017, 27 : 17 - 19
[6] Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Daniel Claassen
Mark Lew
Clinical Autonomic Research, 2017, 27 : 13 - 14
[7] Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Claassen, Daniel
Lew, Mark
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S13 - S14
[8] Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
Kremens, Daniel
Lew, Mark
Claassen, Daniel
Goodman, Brent P.
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S29 - S31
[9] Impact of droxidopa treatment in patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension (study 306)
Isaacson, S. H.
Hauser, R. A.
Szakacs, C. B. N.
Cioffi, C. C.
MOVEMENT DISORDERS, 2013, 28 : S167 - S167
[10] Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
Daniel Kremens
Mark Lew
Daniel Claassen
Brent P. Goodman
Clinical Autonomic Research, 2017, 27 : 29 - 31

← 1 2 3 →